Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Guggenheim Cuts Price Target on Phibro Animal Health (PAHC) Following 3Q Miss
May 10, 2016 2:06 PM EDTGuggenheim maintained a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and cut the price target to $26.00 (from $34.00), following the company's 3Q earnings report. PAHC reported F'3Q16 EPS of $0.38, $0.03 lower than consensus. PAHC lowered its F'16 revenue and EPS guidance to $745MM-$750MM, and... More
